Phase II trial of chemoradiotherapy using weekly gemcitabine (GEM) in patients (pts) with locally advanced pancreatic cancer (PC). Final results No significant financial relationships to disclose.
Combination chemotherapy with docetaxel and gemcitabine in patients with metastatic or locally advanced pancreatic carcinoma: results of a multicenter phase II study No significant financial ...
The American Medical Association has released an update to the CPT Category II code list. The update contains many revisions, significant new codes and deleted codes, according to an AAPC report. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results